Merck KGaA has received US FDA Fast Track designation for its generalised myasthenia gravis (gMG) drug treatment. Current ...

The biggest prostate cancer screening trial in decades has been launched in the UK, with the goal of finding the best way to ...

The US Food and Drug Administration (FDA) has approved PADCEV (enfortumab), in combination with Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase), as a treatment for ...

These plans come as part of AstraZeneca’s planned $50bn US manufacturing investment, which the company announced in July.

Without adapting JCA to include assessment of real world data (RWD) and broader benefits, vaccines may be undervalued, ...

Novartis has reported positive top-line results from the phase 3 KALUMA trial evaluating KLU156 (ganaplacide/lumefantrine, or ...

Merck (known as MSD outside the US and Canada) has entered into a definitive agreement to acquire Cidara Therapeutics, a ...

Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, ...

PMEA returned on 19 November to the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Johnson & Johnson (J&J) has received a positive recommendation from the UK’s National Institute for Health and Care ...

VML Portugal has announced the launch of VML Health, with pharma communications veteran Mariana Marta dos Santos being ...

It’s reshaping what awareness, diagnosis and care must look like in the UK and across Europe. New efforts, such as ‘Jess’s ...